Multisystem Inflammatory Syndrome and Autoimmune Diseases Following COVID-19: Molecular Mechanisms and Therapeutic Opportunities

Multisystem Inflammatory Syndrome and Autoimmune Diseases Following COVID-19: Molecular Mechanisms and Therapeutic Opportunities

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), has led to huge concern worldwide. Some SARS-CoV-2 infected patients may experience post–COVID-19 complications such as multisystem inflammatory syndrome, defined by symptoms including fever...

Full description

Bibliographic Details
Main Authors: Parastoo Hosseini, Mohammad Sadegh Fallahi, Gisou Erabi, Majid Pakdin, Seyed Mahdi Zarezadeh, Arezoo Faridzadeh, Sarina Entezari, Arina Ansari, Mohadeseh Poudineh, Niloofar Deravi
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Molecular Biosciences
Subjects:
autoimmune disease
COVID-19
SARS-CoV2
multisystem inflammatory syndrome
multisystem inflammatory syndrome in children (MIS-C)
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2022.804109/full

Internet

https://www.frontiersin.org/articles/10.3389/fmolb.2022.804109/full

Similar Items